期刊
BRAIN RESEARCH BULLETIN
卷 178, 期 -, 页码 82-96出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.brainresbull.2021.11.009
关键词
Parkinson's disease; ECS; CB1R; CB2R; Basal ganglia
资金
- Kerman University of Medical Sciences [97000860]
- Kerman, Iran
Parkinson's disease is a neurodegenerative disorder characterized by the loss of dopaminergic neurons. Recent studies have shown that modulation of GABA and cannabinoid receptors can improve motor functions in Parkinson's disease patients. Therefore, investigating the changes of cannabinoid receptors in different stages of the disease and utilizing them in treatment could be significant for Parkinson's disease management.
Parkinson's disease (PD) is characterized by the progressive loss of dopaminergic (DAergic) neurons of the substantia nigra pars compacta (SNc) by neurodegeneration. Recent findings in animal models of PD propose tonic inhibition of the remaining DA neurons through GABA release from reactive glial cells. Movement dysfunctions could be ameliorated by promotion of activity in dormant DA cells. The endocannabinoid system (ECS) is extensively present in basal ganglia (BG) and is known as an indirect modulator of DAergic neurotransmission, thus drugs designed to target this system have shown promising therapeutic potential in PD patients. Interestingly, down/up-regulation of cannabinoid receptors (CBRs) varies across the different stages of PD, suggesting that some of the motor/non-motor deficits may be related to changes in CBRs. Determination of the profile of changes of these receptors across the different stages of PD as well as their neural distribution within the BG could improve understanding of PD and identify pathways important in disease pathobiology. In this review, we focus on temporal and spatial alterations of CBRs during PD in the BG. At present, as inconclusive, but suggestive results have been obtained, future investigations should be conducted to extend preclinical studies examining CBRs changes within each stage in controlled clinical trials in order to determine the potential of targeting CBRs in management of PD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据